Crystallography is rarely a straight line, it’s an iterative process. Each stage can reveal new data that shapes the next step. For example, an expression test might uncover a degradation product, prompting us to look for a more stable, crystallizable region of the target protein.

When that happens, we confirm domain boundaries and reorder the gene to optimize results. To keep projects efficient and transparent, we break them into clear stages with Stop/Go decision points.

Graphic illustrating the iterative process of protein crystallography with Stop/Go decision points, showing sequential stages from expression testing to crystallization and structural optimization.

Protein Construct Design

We design constructs to give your protein the best chance to succeed from the start:

• Bioinformatics and modelling guide every decision

• Affinity tags simplify expression and purification while meeting end-use requirements

• Chimeras, mutations, truncations, deletions tailored to your project needs.

• IMPROvER software enhances membrane protein stability.

Crystallization

We combine precision and automation delivering an efficient process to maximize crystallization success:

  • Initial screening with commercial and in-house sparse matrix screens
  • Thermofluor screens to explore buffers, pH, additives, substrates, cofactors, ions
  • Co-crystallization with tool compounds when required
  • Fragment screening options available
  • Automated crystallization and imaging using:
    • Dragonfly for screen optimization
    • Mosquito ultra-low volume liquid handling to minimize protein use
    • Formulatrix Rock Imager 1000 plate hotel
    • Rockmaker data analysis
    • CrystalShifter for efficient crystal harvesting

X-Ray Data Collection

We generate high-quality data at leading synchrotron facilities

• Access to third-generation light sources such as Diamond, ESRF, Soleil, and SLS

• Reserved data collection slots for predictable timelines

• Flexibility beamtime for accelerated turnaround when needed

Structure Determination

Our team applies proven methods to deliver accurate informative structures:

• Molecular Replacement or de novo phasing using Se-Met or SAD/MAD

• Multiple rounds of refinement for precision and reliability

Our talented crystallography team brings decades of experience in solving X-ray crystal structures over a wide range of different protein classes. Our proven expertise ranges from de-novo protein structure determination of challenging targets to delivering rapid turnaround protein-ligand complexes as well as managing X-ray based FBLG projects.

Profile picture of Derek Ogg

Derek Ogg

Chief Scientific Officer and Protein Crystallographer

Featured image for testimonial by Derek Ogg
Loading…
Fragment Screening for VHL Binders & PROTAC Development
Fragment Screening for VHL Binders & PROTAC Development
The Von Hippel-Lindau (VHL) E3 ligase is one of the most widely used protein…
Posters

Related Solutions

Protein & Structure
Fragment Based Drug Discovery
Cryo-EM
Protein NMR